Variations in astrocyte and fibroblast response due to biomaterial particulates in vitro

Journal of Biomedical Materials Research - Part A

Volumn 85, Issue 1, 2008, Pages 14-24

  De Guzman, Roche C ^a   VandeVord, Pamela J ^a  

^a Wayne State University   (United States)

Author keywords

Biomaterial particles; Cytotoxicity; Fibroblast; Proliferation; Reactive astrocyte

Indexed keywords

BIOMATERIALS; CELL DEATH; CYTOTOXICITY; FIBROBLASTS; MOLECULAR WEIGHT; POLYETHYLENES; POLYMETHYL METHACRYLATES;

BIOMATERIAL PARTICLES; PROLIFERATION; REACTIVE ASTROCYTES; SCAR DEVELOPMENT;

COBALT ALLOYS;

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ALLOY; BIOMATERIAL; CHROMIUM; COBALT; COLLAGEN TYPE 4; GLIAL FIBRILLARY ACIDIC PROTEIN; NESTIN; POLY(METHYL METHACRYLATE); TITANIUM; ULTRA HIGH MOLECULAR WEIGHT POLYETHYLENE; VIMENTIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; ASTROCYTE; CELL DEATH; CELL LINE; CELL PROLIFERATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; DRUG DETERMINATION; FIBROBLAST; GLIA; IN VITRO STUDY; MENINX; MICROSCOPY; MODEL; NONHUMAN; ORTHOPEDICS; PARTICULATE MATTER; SCAR; UPREGULATION;

ANIMALS; ASTROCYTES; BIOCOMPATIBLE MATERIALS; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMIUM ALLOYS; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLASTS; PARTICULATE MATTER; POLYETHYLENES; POLYMETHYL METHACRYLATE; RATS; TITANIUM;

EID: 40449090526     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.31516     Document Type: Article

References (45)

1. Mofid MM, Thompson RC, Pardo CA, Manson PN, Vander Kolk CA. Biocompatibility of fixation materials in the brain. Plast Reconstr Surg 1997;100:14-20. discussion 21-2.
2. Polikov VS, Tresco PA, Reichert WM. Response of brain tissue to chronically implanted neural electrodes. J Neurosci Methods 2005;148:1-18.
3. Yuen TG, Agnew WF, Bullara LA. Tissue response to potential neuroprosthetic materials implanted subdurally. Biomaterials 1987;8:138-141.
4. Mohanty M, Baby S, Menon KV. Spinal fixation device: A 6-year postimplantation study. J Biomater Appl 2003;18:109-121.
5. Fawcett JW, Asher RA. The glial scar and central nervous system repair. Brain Res Bull 1999;49:377-391.
6. Liu F, Luo ZJ, You SW, Jiao XY, Meng XM, Shi M, Wang CT, Ju G. Significance of fixation of the vertebral column for spinal cord injury experiments. Spine 2003;28:1666-1671.
7. Stensaas SS, Stensaas LJ. Histopathological evaluation of materials implanted in the cerebral cortex. Acta Neuropathol (Berl) 1978;41:145-155.
8. Yturraspe DJ, Lumb WV, Young S, Gorman HA. Neurological and pathological effects of second lumbar spondylectomy and spinal column shortening in the dog. J Neurosurg 1975;42:47-58.
9. Verlaan JJ, Oner FC, Dhert WJ. Anterior spinal column augmentation with injectable bone cements. Biomaterials 2006;27:290-301.
10. Murai N, Oda Y, Nagata I, Takahashi JA, Ishikawa M, Kikuchi H, Nakamura T. Neurotoxicity testing of a new bioactive bone cement. Neurol Med Chir (Tokyo) 1997;37:201-204.
11. Pekny M, Nilsson M. Astrocyte activation and reactive gliosis. Glia 2005;50:427-434.
12. Sofroniew MV. Reactive astrocytes in neural repair and protection. Neuroscientist 2005;11:400-407.
13. Wu VW, Schwartz JP. Cell culture models for reactive gliosis: New perspectives. J Neurosci Res 1998;51:675-681.
14. Liberto CM, Albrecht PJ, Herx LM, Yong VW, Levison SW. Pro-regenerative properties of cytokine-activated astrocytes. J Neurochem 2004;89:1092-1100.
15. Liesi P, Kauppila T. Induction of type IV collagen and other basement-membrane-associated proteins after spinal cord injury of the adult rat may participate in formation of the glial scar. Exp Neurol 2002;173:31-45.
16. Hirano S, Yonezawa T, Hasegawa H, Hattori S, Greenhill NS, Davis PF, Sage EH, Ninomiya Y. Astrocytes express type VIII collagen during the repair process of brain cold injury. Biochem Biophys Res Commun 2004;317:437-443.
17. Van Wagoner NJ, Oh JW, Repovic P, Benveniste EN. Interleukin-6 (IL6) production by astrocytes: Autocrine regulation by IL6 and the soluble IL6 receptor. J Neurosci 1999;19:5236-5244.
18. Kruger S, Sievers J, Hansen C, Sadler M, Berry M. Three morphologically distinct types of interface develop between adult host and fetal brain transplants: Implications for scar formation in the adult central nervous system. J Comp Neurol 1986;249:103-116.
19. Li MS, David S. Topical glucocorticoids modulate the lesion interface after cerebral cortical stab wounds in adult rats. Glia 1996;18:306-318.
20. Wooley PH, Morren R, Andary J, Sud S, Yang SY, Mayton L, Markel D, Sieving A, Nasser S. Inflammatory responses to orthopaedic biomaterials in the murine air pouch. Biomaterials 2002;23:517-526.
21. Kawai K, Terada S, Yokota O, Fujita D, Ishizu H, Kuroda S. Lectin cytochemical demonstration of glucose- and mannose-containing glycoconjugates on human reactive astrocytes. Virchows Arch 2002;441:584-588.
22. al-Ali SY, al-Hussain SM. An ultrastructural study of the phagocytic activity of astrocytes in adult rat brain. J Anat 1996;188(Part 2):257-262.
23. Kalmar B, Kittel A, Lemmens R, Kornyei Z, Madarasz E. Cultured astrocytes react to LPS with increased cyclooxygenase activity and phagocytosis. Neurochem Int 2001;38:453-461.
24. Renner R. Redrawing the dose-response curve. Environ Sci Technol 2004;38:90A-95A.
25. Ostrow LW, Sachs F. Mechanosensation and endothelin in astrocytes - Hypothetical roles in CNS pathophysiology. Brain Res Brain Res Rev 2005;48:488-508.
26. Burke JM, McDonald HR, Neuwirth J, Lewandowski M. Titanium retinal tacks with pneumatic insertion. Histologic evaluation in rabbits. Arch Ophthalmol 1987;105:404-408.
27. Teixeira A, Chaverot N, Strosberg AD, Cazaubon S. Differential regulation of cyclin D1 and D3 expression in the control of astrocyte proliferation induced by endothelin-1. J Neurochem 2000;74:1034-1040.
28. Cazaubon S, Chaverot N, Romero IA, Girault JA, Adamson P, Strosberg AD, Couraud PO. Growth factor activity of endothelin-1 in primary astrocytes mediated by adhesion-dependent and -independent pathways. J Neurosci 1997;17:6203-6212.
29. Lightfoot HM Jr, Lark A, Livasy CA, Moore DT, Cowan D, Dressler L, Craven RJ, Cance WG. Upregulation of focal adhesion kinase (FAK) expression in ductal carcinoma in situ (DCIS) is an early event in breast tumorigenesis. Breast Cancer Res Treat 2004;88:109-116.
30. Yip SS, Crew AJ, Gee JM, Hui R, Blamey RW, Robertson JF, Nicholson RI, Sutherland RL, Daly RJ. Up-regulation of the protein tyrosine phosphatase SHP-1 in human breast cancer and correlation with GRB2 expression. Int J Cancer 2000;88:363-368.
31. Anteby EY, Ayesh S, Shochina M, Hamani Y, Schneider T, Al-Shareef W, Hochberg A, Ariel I. Growth factor receptor-protein bound 2 (GRB2) upregulation in the placenta in preeclampsia implies a possible role for ras signalling. Eur J Obstet Gynecol Reprod Biol 2005;118:174-181.
32. Mhawech-Fauceglia P, Fischer G, Beck A, Cheney RT, Herrmann FR. Raf1, Aurora-A/STK15 and E-cadherin biomarkers expression in patients with pTa/pT1 urothelial bladder carcinoma; a retrospective TMA study of 246 patients with long-term follow-up. Eur J Surg Oncol 2006;32:439-444.
33. Hattrup CL, Gendler SJ. MUC1 alters oncogenic events and transcription in human breast cancer cells. Breast Cancer Res 2006;8:R37.
34. Yao Q, Luo JR, Chen JH, Zhang JL, Yuan SF, Ling R, Wang L. [Expression and activation of MAPK pathway signaling molecules in human breast cancer cell lines]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2004;20:328-330.
35. Scholl FA, Dumesic PA, Khavari PA. Effects of active MEK1 expression in vivo. Cancer Lett 2005;230:1-5.
36. Chuang CF, Ng SY. Functional divergence of the MAP kinase pathway. ERK1 and ERK2 activate specific transcription factors. FEBS Lett 1994;346:229-234.
37. Pentreath VW, Slamon ND. Astrocyte phenotype and prevention against oxidative damage in neurotoxicity. Hum Exp Toxicol 2000;19:641-649.
38. Leibnitz L, Kastner I, Bar B. [Morphologic and histochemical changes in the secondary focus following cobalt-induced epileptogenic bioelectrical activity of the visual cortex in the adult rat]. J Hirnforsch 1985;26:601-614.
39. Valko M, Morris H, Cronin MT. Metals, toxicity and oxidative stress. Curr Med Chem 2005;12:1161-1208.
40. Nicholas AP, McInnis C, Gupta KB, Snow WW, Love DF, Mason DW, Ferrell TM, Staas JK, Tice TR. The fate of biodegradable microspheres injected into rat brain. Neurosci Lett 2002;323:85-88.
41. Tansey FA, Cammer W. Differential uptake of dextran beads by astrocytes, macrophages and oligodendrocytes in mixed glial-cell cultures from brains of neonatal rats. Neurosci Lett 1998;248:159-162.
42. Chang GH, Barbaro NM, Pieper RO. Phosphatidylserine-dependent phagocytosis of apoptotic glioma cells by normal human microglia, astrocytes, and glioma cells. Neuro Oncol 2000;2:174-183.
43. Savill J, Fadok V, Henson P, Haslett C. Phagocyte recognition of cells undergoing apoptosis. Immunol Today 1993;14:131-136.
44. Schulte-Hermann R, Grasl-Kraupp B, Bursch W. Dose-response and threshold effects in cytotoxicity and apoptosis. Mutat Res 2000;464:13-18.
45. Kim JK, Lee WK, Lee EJ, Cho YJ, Lee KH, Kim HS, Chung Y, Kim KA, Lim Y. Mechanism of silica- and titanium dioxide-induced cytotoxicity in alveolar macrophages. J Toxicol Environ Health A 1999;58:437-450.